Overview
The entry of technology players into healthcare, alongside empowered consumers and payers’ singular focus on cost-effective outcomes, is forcing change across all of pharma’s traditional functions. Modern pharma needs to build new kinds of relationships, with each other, with tech players, and with healthcare providers and payers.
The entry of technology players into healthcare, alongside empowered consumers and payers’ singular focus on cost-effective outcomes, is forcing change across all of pharma’s traditional functions. Modern pharma needs to build new kinds of relationships, with each other, with tech players, and with healthcare providers and payers.
Table of Contents
OVERVIEW
THE REIMAGINING OF HEALTHCARE
CASE STUDIES
TECHNOLOGY FIRMS ARE REAL COMPETITORS
DIGITAL PRODUCTS CAN ENHANCE DRUG PORTFOLIOS
CHALLENGES TO EMBRACING NEW TECHS AND NEW PARTNERS
LESSONS FROM OTHER SECTORS
21ST CENTURY PHARMA: COLLABORATIVE SOLUTION PROVIDERS
APPENDIX
LIST OF FIGURES
LIST OF TABLES